April 18, 2024 by Chain Drug Review
Aurigene, Vipergen
Pharmacy
HYDERABAD, India — Aurigene Pharmaceutical Services Ltd., a global contract research, development, and manufacturing services organization (CRDMO); and Vipergen ApS, a niche small-molecule drug discovery service provider specializing in DNA encoded library (DEL) technologies; have partnered to co-market and offer DEL screening technologies as a standalone service or as an integrated drug discovery service. The
April 12, 2024 by Chain Drug Review
CVS, Harrison
Featured Articles, Leading Headlines
WOONSOCKET, R.I. — CVS vice president of merchandising for beauty and personal care Andrea Harrison has left the company for “a new opportunity,” she wrote on LinkedIn. After 19 years with CVS, “it was a bittersweet departure with so many memories and so hard leaving an amazing team,” she wrote. “There are more people to
April 8, 2024 by Chain Drug Review
Bayer, Dr. Reddy’s, vericiguat
Pharmacy, Supplier News
HYDERABAD, India — Dr. Reddy’s Laboratories Ltd. and Bayer have partnered to market and distribute a second brand of vericiguat in India. Under the terms of their agreement, Bayer has granted nonexclusive rights to Dr. Reddy’s under the brand name Gantra. Vericiguat, a soluble guanylate cyclase (sGC) stimulator, in India, is indicated, along with guideline-based
March 28, 2024 by Chain Drug Review
second quarter, VillageMD, WBA
Featured Articles, Leading Headlines
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. topped analysts’ forecasts for second quarter revenue and adjusted earnings. WBA posted adjusted earnings per share of $1.20, well above Wall Street’s predicted 82 cents. Sales of $37.05 billion exceeded the estimated $36.22 billion. The company posted a net loss of $5.91 billion, or $6.85 per share, for
March 27, 2024 by Chain Drug Review
Dr. Reddy’s, Sanofi
Pharmacy, Supplier News
HYDERABAD, India — Dr. Reddy’s Laboratories Ltd. has entered into an exclusive partnership with Sanofi Healthcare India Private Ltd. to promote and distribute the latter’s vaccine brands across private markets in India. Under the arrangement, Dr. Reddy’s will have exclusive rights to promote and distribute Sanofi’s well established and trusted paediatric and adult vaccine brands
March 20, 2024 by Chain Drug Review
Dr. Reddy’s, Versavo
Pharmacy, Supplier News
HYDERABAD, India — Dr. Reddy’s Laboratories, a global pharmaceutical company, has introduced Versavo (bevacizumab) in the United Kingdom. Dr. Reddy’s Versavo is a biosimilar of Avastin and indicated for the treatment of several types of cancers, including metastatic colorectal cancer, advanced non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, advanced cervical cancer,
March 18, 2024 by Chain Drug Review
Circana, Growth Leaders
Leading Headlines
CHICAGO – Circana, a leading advisor on the complexity of consumer behavior, on Monday issued its annual Growth Leaders rankings. The firm analyzed the growth performance of hundreds of public and private consumer packaged goods (CPG) companies ranging from $100 million to $60 billion in annual sales to develop the rankings. Circana will highlight the
March 18, 2024 by Chain Drug Review
Camber
Pharmacy, Supplier News
PiISCATAWAY, N.J. — Camber Pharmaceuticals has added gabapentin tablets (generic for Gralise) to its portfolio. Camber already offers gabapentin tablets and capsules (generic for Neurontin). Generics for Gralise and Neurontin are not interchangeable. Gabapentin tablets (generic for Gralise) are indicated for the management of postherpetic neuralgia (PHN). Gabapentin tablets (generic for Gralise) 300 mg and
March 18, 2024 by Chain Drug Review
AllianceRx Walgreens, Vivjoa
Leading Headlines
DEERFIELD, Ill. — Specialty pharmacy patients now have exclusive access to VIVJOA through AllianceRx Walgreens Pharmacy. VIVJOA (oteseconazole), manufactured by Mycovia Pharmaceuticals, Inc., is the first FDA-approved medication to reduce the incidence of recurrent vulvovaginal candidiasis (RVVC) in post-menopausal women or women who are not of reproductive potential. The addition of this medication brings Walgreens enterprise specialty’s number of exclusive
March 18, 2024 by Chain Drug Review
NRF, Retail employment
Featured Articles, Leading Headlines
WASHINGTON – The retail industry continues to be a top employer, according to a new report released by the National Retail Federation on Monday, which found that retailers supported 55 million full-time and part-time jobs in 2022, accounting for 26% of total U.S. employment. “The retail industry continues to expand in every way possible, from
March 14, 2024 by Chain Drug Review
CRN files lawsuit challenging unconstitutional law that restricts access to health products
Leading Headlines, Retail News, Supplier News
WASHINGTON — The Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry, today announced the filing of a lawsuit challenging the constitutionality of a recently enacted New York law that would restrict consumer access to safe and beneficial health products. The suit seeks an injunction to prohibit
March 7, 2024 by Chain Drug Review
Bast, Greater Than One
Supplier News
NEW YORK — Andrew Bast will be rejoining Media marketing and technology agency Greater Than One as chief strategy officer. Bast brings the art and science of strategic planning to forge dynamic, insight-driven strategies which resonate deeply with clients’ customers, the agency says. He has launched and grown many brands, including Nexium, Rexulti, Seroquel, Enbrel,
February 28, 2024 by Chain Drug Review
Eckerd, Stew Turley
Leading Headlines, Retail News
TAMPA — Stew Turley, who guided the evolution of Eckerd Corp. for three decades, died last week at his home in Florida after a battle with lymphoma. He was 89. During the course of his tenure at the retailer, which began in 1966 when he was named manager of non-drug operations, Eckerd grew to 2,778
February 21, 2024 by Chain Drug Review
Greater Than One, Valdez
Supplier News
NEW YORK — Jason Valdez has been promoted to chief operating officer of Greater Than One, a media marketing and technology agency focused on healthcare. He is responsible for overall operations and ensuring the agency’s mission of building better healthcare experiences for customers. He will work directly with CEO Elizabeth Apelles to align the agency
